Drug recall · March 14, 2018
RANITIDINE Tablets recall
Why: Failed Stability Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10
- Lots / codes
Lots: 0113064 Exp. 03/2018, 0114628 Exp. 08/2018, 0115189 Exp. 08/2018, 0115462 Exp. 09/2018
- Quantity
- 17,192 cartons (1,719,200 tablets)
- Company
- Mckesson Packaging Services, Concord, NC
- Distribution
- Nationwide
- Initiated
- February 26, 2018 · Voluntary: Firm initiated
- Classified
- July 9, 2018
- Reported
- March 14, 2018
- Ended
- September 15, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ranitidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.